Andrew Sinclair's Net Worth

$882 Million

Estimate Recalculated Feb 7, 2024 04:05PM EST

Who is Andrew Sinclair?

Andrew Sinclair has an estimated net worth of $882 Million. This is based on reported shares across multiple companies, which include Verona Pharma plc, Adicet Bio, Inc., Sierra Oncology, Inc., and SOLENO THERAPEUTICS INC.

SEC CIK

Andrew Sinclair's CIK is 0001762451

Past Insider Trading and Trends

2021 was Andrew Sinclair's most active year for acquiring shares with 10 total transactions. Andrew Sinclair's most active month to acquire stocks was the month of May. 2022 was Andrew Sinclair's most active year for disposing of shares, totalling 6 transactions. Andrew Sinclair's most active month to dispose stocks was the month of June. 2018 saw Andrew Sinclair paying a total of $7,499,784.69 for 9,358,544 shares, this is the most they've acquired in one year. In 2022 Andrew Sinclair cashed out on 2,487,097 shares for a total of $112,331,312.50, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Verona Pharma plc (VRNA) Snapshot price: $16.47

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Aug 9
Form 3/A
0
0
Form 3
0
0
No matching records found

Adicet Bio, Inc. (ACET) Snapshot price: $3.2175

Investor

Andrew Sinclair owns 2,121,285 units of Common Stock which is worth $6,825,234.49. From 2021 to 2023 Andrew Sinclair acquired a total of 1,005,900 shares in Adicet Bio, Inc. at a cost of $14,000,000.00.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Aug 14
Form 4
5.9K
5.9K
Jun 1
Form 4
0
0
Jun 2
Form 4/A
+30.95%
500K
$14.00
$7,000,000.00
2.12M
Dec 8
Form 4
+30.47%
500K
$14.00
$7,000,000.00
2.14M
Dec 8
Form 4
0
0
Apr 30
Form 4/A
0
0
Mar 2
Form 3/A
0
0
Form 4
0
0
Mar 2
Form 3
0
0
No matching records found

Sierra Oncology, Inc. No price found

Investor

Andrew Sinclair owns 876,656 units of Common Stock. Andrew Sinclair used to own units in Common Stock, $0.001 par value but no longer holds any shares there. From 2019 to 2022 Andrew Sinclair acquired a total of 2,179,836 shares in Sierra Oncology, Inc. at a cost of $7,844,617.20, Andrew also disposed a total of 1,314,127 shares of Sierra Oncology, Inc. equalling to $72,276,985.00.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-1.31M
$55.00
-$72,276,985.00
0
Jul 1
Form 4
+49.90%
437.47K
$17.93
$7,844,617.20
1.31M
Jan 28 - Jan 31
Form 4
0
0
Jun 8
Form 4
0
0
Jun 9
Form 4/A
+16,086.41%
871.24K
876.66K
Jan 29
Form 4
+16,081.32%
871.13K
876.54K
Jan 29
Form 4
0
0
Nov 29
Form 3
0
0
No matching records found

SOLENO THERAPEUTICS INC (SLNO) Snapshot price: $46.625

Investor

Andrew Sinclair owns 18,022,602 units of Common Stock which is worth $840,303,818.25. From 2018 to 2023 Andrew Sinclair acquired a total of 18,022,602 shares in SOLENO THERAPEUTICS INC at a cost of $15,730,829.70.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
May 25 - May 26
Form 4
0
0
Form 4
0
0
Jun 1
Form 4
+74.93%
7.72M
18.02M
Mar 29
Form 4
0
0
Jun 1
Form 4
0
0
Jan 8
Form 4
+47.83%
3.33M
$1.65
$5,499,994.50
10.3M
Jun 26
Form 4
0
0
May 18
Form 4
+49.26%
2.3M
$1.20
$2,760,000.00
6.97M
Oct 25
Form 4
0
0
Jun 10
Form 4
4.67M
$1.60
$7,470,835.20
4.67M
Dec 21
Form 3
0
0
No matching records found